계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
4BIO Capital
company
About
4BIO Capital is a specialist fund focused on investing in and building early stage advanced therapy companies
- 1 - 10
Highlights
Details
- Industries
- Genetics
- Founded date
- Dec 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- Venture Capital
4BIO Ventures is a London-based firm investing in venture capital and public equities in life sciences. They are focused on advanced therapies addressing high unmet medical and social needs.4BIO Capital Partners is an emerging asset manager focusing on private equity and venture capital in high growth and high return segments of biotech - biologics, gene and cell therapy and bioinformatics.
Investments
Number of Investments
Number of Lead Investments
5
0
4BIO Capital has made 5 investments. Their most recent investment was on
Dec 6, 2022, when Entact Bio raised $81M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 6, 2022
Entact Bio
|
Series A | $81M | Biopharma | — |
|
Sep 21, 2022
Carisma Therapeutics
|
Series C | $30M | Biotechnology | — |
|
Mar 1, 2021
Carisma Therapeutics
|
Series B | $12M | Biotechnology | — |
|
Jan 1, 2018
Autolus
|
Post-IPO Equity | — | Biopharma | — |
|
Jan 1, 2017
Cellectis
|
Post-IPO Equity | — | Biopharma | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
